Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.
This is the first report of vaginal erythematous areas associated with the use of a levonorgestrel-releasing contraceptive ring. Of 139 female subjects, 48 developed lesions of varying size and degrees of redness. Sixteen of these have undergone serial colposcopy and thirteen have also had biopsy examinations, which revealed acetowhite areas and, histologically, chronic inflammation with widely dilated vessels and frequently with thinning of the epithelium. The cause remains uncertain but hormonal, chemical and physical effects might all have a role.
Margaret Pyke Memorial Trust, Margaret Pyke Centre, London, UK.
W
W
Bounds
A
A
Szarewski
D
D
Lowe
J
J
Guillebaud
D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D001706:Biopsy; D003274:Contraceptive Devices, Female / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D016912:Levonorgestrel / Q000008:administration & dosage / Q000009:adverse effects*; D014621:Vagina / Q000187:drug effects*
D016912:Levonorgestrel